Skip to content
PolyBio Industries Ltd. Farm-to-Pharma · Industrial Biotechnology

Investment & partnership

Partner with PolyBio

We are building an industrial biotechnology platform in Bangladesh, and we are open to investors, technology partners, institutions and industrial counterparties who want to build it with us.

Pathways

Six ways to work with us

Invest with us

Equity participation in a development-stage industrial platform with a defined Phase 1 and a longer product roadmap.

  • Strategic investors
  • Impact investors
  • Institutional capital
Start a conversation →

Technology partnership

Process technology, engineering, equipment supply and technical collaboration for Phase 1 and later platform layers.

  • Process technology providers
  • Engineering firms
  • Equipment suppliers
Start a conversation →

Strategic partnership

Offtake, distribution and long-term industrial alignment with buyers of refined ingredients.

  • Pharmaceutical manufacturers
  • Food industry
  • Industrial buyers
Start a conversation →

Institutional partnership

Development finance, concessional instruments, research collaboration and public-sector programmes.

  • Development finance institutions
  • Research institutions
  • Government programmes
Start a conversation →

Supply partnership

Raw material aggregation, farmer sourcing programmes and agricultural supply chain development.

  • Farmer organisations
  • Aggregators
  • Agricultural programmes
Start a conversation →

Corporate development

Introductions, advisory relationships and structured discussions ahead of a formal process.

  • Advisors
  • Banks
  • Corporate partners
Start a conversation →

Phase 1 snapshot

The project in outline

Every line is labelled. Planning assumptions are not results. Read the full notice at the bottom of this page.

ItemBasisStatus
Phase 1 Pharmaceutical-grade native potato starch facility Planning assumption
Planned location Northern Bangladesh (Rangpur region) Planning assumption
Processing capacity 8 TPH · 100 MT/day · 300 days/year Planning assumption
Annual raw material intake approx. 30,000 MT/year Planning assumption
CAPEX planning range BDT 85–90 crore Planning assumption
Target financing structure 30% equity / 70% debt Planning assumption
Technology partner SiccaDania B.V., Netherlands Planning assumption
Corporate status Registered 03 August 2026 · RJSC C-212591/2026 Confirmed

Investment case

Why this platform

Import substitution with a domestic buyer base

The output substitutes an ingredient Bangladeshi manufacturers already buy from abroad.

Established process technology

Phase 1 is designed around proven European starch technology rather than unproven equipment.

Platform economics

The same raw material base and refining assets extend into modified starches, protein, nutrition and energy recovery.

Circular by design

By-product recovery is built into the process design, improving both economics and environmental performance.

Development impact alignment

Farmer income, rural employment and supply chain localisation are structural to the model, not a side programme.

Clear governance

A registered company with a defined board, defined corporate identity and disciplined disclosure practice.

Process

How an engagement usually starts

  1. 01

    Initial contact

    Introduce your organisation and the type of partnership you are exploring.

  2. 02

    Information pack

    We share the corporate pitch deck and respond to first-round questions.

  3. 03

    Structured discussion

    Technical, financial and commercial review with the relevant counterparties.

  4. 04

    Documentation

    Formal documentation and due diligence under an agreed process.

Contact corporate development

info@polybio.com.bd · +880 1909-441344

Contact us

Important notice. Nothing on this page is an offer of securities, an invitation to invest, or a commitment by PolyBio Industries Ltd. or any third party. Figures shown are planning assumptions or supplier-provided data and are subject to feasibility work, financing and regulatory processes. No financing has been closed and no equipment supply agreement is represented as executed.